NCT03027648

Levonorgestrel-releasing Intrauterine System for the Treatment of Symptomatic Adenomyosis

Cohort Study of Levonorgestrel-releasing Intrauterine System for the Treatment of Symptomatic Adenomyosis

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 1,100 (actual)
• Sponsor: Peking Union Medical College Hospital · Academic / Other
• Sex: Female
• Age: 20 Years – 45 Years
• Healthy volunteers: Not accepted

Summary

Objective: To investigate the effects of levonorgestrel-releasing intrauterine system (LNG-IUS) for symptomatic adenomyosis. Methods: From December, 2006 to December, 2014, symptomatic patients of adenomyosis diagnosed (with dysmenorrhea and/or menorrhea) by transvaginal ultrasound in outpatient or inpatient clinics of Peking Union Medical College Hospital were given the treatment of LNG-IUS. Before and after placement of LNG-IUS, during each following period, all the parameters were recorded prospectively, including carrying status of IUS, symptoms and scores of dysmenorrhea, menstruation scores, biochemical indicators, physical parameters, menstruation patterns and adverse effects. Primary outcome measures: symptoms and scores of dysmenorrhea and menorrhea Second outcome measures: carrying status of IUS

Conditions

• Adenomyosis

Interventions

Type	Name	Description
PROCEDURE	Placement of levonorgestrel-releasing intrauterine system	All the patients accepted treatment of levonorgestrel-releasing intrauterine system

Timeline

• Start date: 2006-12-01
• Primary completion: 2014-12-01
• Completion: 2017-01-01
• First posted: 2017-01-23
• Last updated: 2017-01-23